Fresh Insights on Cell Therapy for Cerebral Palsy
A new study on cell therapy for cerebral palsy has, for the first time, directly compared the efficacy of two different treatments. Although more research is needed, the study’s results offer valuable insights for future clinical trials tackling this challenging...
Leukemia Treatment Derived From Cord Blood Gains FDA Approval for Clinical Trials
A CAR-T cell therapy for acute lymphoblastic leukemia[1] has recently been approved by the FDA for use in clinical trials in the United States. The therapy is based on cells derived from allogeneic (donor) umbilical cord blood; it is the very first such treatment to...
Toddler’s Rare Leukemia Treated by Sister’s Cord Blood
After two planned transplants from unrelated donors fell through at the very last minute, Australian three-year-old Tommy Bacon is now in remission from a rare, dangerous form of leukemia following a transplant of the stem cells from his baby sister’s cord blood.[1]...
Combination Therapy Using Umbilical Cord Stem Cells Could Be Key to Treating Spinal Cord Injuries
A new study on the effectiveness of treatment for spinal cord injuries indicates that a combination therapy, including epidural electrical stimulation (EES) as well as neural stem cells and umbilical cord stem cells, could offer better results than any one treatment...


